News dated July 5, 2023. Recently, the "Most Influential List of China's Pharmaceutical Industry" in 2022-2023 has been released, which has attracted the attention of the industry. MedGence won the 2022-2023 China Top 50 Pharmaceutical R&D Awards and the 2022-2023 China Pharmaceutical Industry Law-abiding and Integrity Enterprises Awards, marking that MedGence’s strong R&D strength has once again been recognized by the industry.
The All-China Federation of Industry and Commerce Medical and Pharmaceutical Commercial Association launched the "China's Most Influential Pharmaceutical Industry List" in 2014, which has been held for 9 consecutive sessions so far. With years of accumulated experience and strong industry resources, the Association invited first-class domestic experts to form a selection panel. The event adheres to the principles of open collection, objective data, strict screening, and fair selection. In collaboration with multiple well-known domestic media, it has selected the most influential series in the pharmaceutical industry and has become an authoritative brand activity in China's pharmaceutical industry.
Post time: Aug-01-2023